| Rewiring of human neurodevelopmental gene regulatory programs by human accelerated regions KM Girskis, AB Stergachis, EM DeGennaro, RN Doan, X Qian, ... Neuron 109 (20), 3239-3251. e7, 2021 | 87 | 2021 |
| Genetic differences in the behavioral organization of binge eating, conditioned food reward, and compulsive-like eating in C57BL/6J and DBA/2J strains RK Babbs, JC Kelliher, JL Scotellaro, KP Luttik, MK Mulligan, CD Bryant Physiology & behavior 197, 51-66, 2018 | 21 | 2018 |
| Sex differences in behavioral and brainstem transcriptomic neuroadaptations following neonatal opioid exposure in outbred mice KN Borrelli, EJ Yao, WW Yen, RA Phadke, QT Ruan, MM Chen, ... ENeuro 8 (5), 2021 | 18 | 2021 |
| Genetic basis of thermal nociceptive sensitivity and brain weight in a BALB/c reduced complexity cross JA Beierle, EJ Yao, SI Goldstein, JL Scotellaro, KD Sena, CA Linnertz, ... Molecular Pain 18, 17448069221079540, 2022 | 7 | 2022 |
| Zhx2 is a candidate gene underlying oxymorphone metabolite brain concentration associated with state-dependent oxycodone reward JA Beierle, EJ Yao, SI Goldstein, WB Lynch, JL Scotellaro, AA Shah, ... Journal of Pharmacology and Experimental Therapeutics 382 (2), 167-180, 2022 | 6 | 2022 |
| Rare variation in noncoding regions with evolutionary signatures contributes to autism spectrum disorder risk T Shin, JHT Song, M Kosicki, C Kenny, SG Beck, L Kelley, X Qian, ... medRxiv, 2023 | 3 | 2023 |
| A reduced complexity cross between BALB/c substrains identifies Zhx2 as a candidate gene underlying oxycodone metabolite brain concentration and state-dependent learning of … JA Beierle, EJ Yao, SI Goldstein, JL Scotellaro, KD Sena, O Averin, ... FASEB journal: official publication of the Federation of American Societies …, 2022 | 1 | 2022 |
| 15. ZHX2 IS A CANDIDATE GENE UNDERLYING BRAIN OXYMORPHONE CONCENTRATION AND OXYCODONE STATE-DEPENDENT LEARNING OF OPIOID REWARD IN A BALB/C REDUCED COMPLEXITY CROSS J Beierle, E Yao, J Scotellaro, O Averin, D Moody, G Peltz, M Ferris, ... European Neuropsychopharmacology 51, e48, 2021 | 1 | 2021 |
| Altered gene expression by rare variants in gene promoters confers risk to autism spectrum disorder J Bonacina, L Kelley, S Patel, J Scotellaro, PG Tovar, M O'Connell, ... EUROPEAN JOURNAL OF HUMAN GENETICS 32, 200-200, 2024 | | 2024 |
| A Reduced Complexity Cross Between BALB/c Substrains Identifies Zhx2 as a Candidate Gene Underlying Brain Concentration of the Oxycodone Metabolite Oxymorphone and State … J Beierle, E Yao, S Goldstein, J Scotellaro, O Averin, D Moody, A Emili, ... NEUROPSYCHOPHARMACOLOGY 46 (SUPPL 1), 446-447, 2021 | | 2021 |
| Oxycodone Behaviors in Cacna1h Knockout Mice WB Lynch, JA Beierle, RH Cole, R Bhandari, JL Scotellaro, A Arslan, ... NEUROPSYCHOPHARMACOLOGY 46 (SUPPL 1), 468-469, 2021 | | 2021 |
| Promoter-mediated dysregulation of gene expression in autism spectrum disorder R Doan, J Scotellaro, L Kelley, T Yu, C Walsh Molecular Genetics and Metabolism 132, S108, 2021 | | 2021 |
| Behavioral and Transcriptomic Adaptations Induced by Neonatal Opioid Exposure in Outbred Mice E Yao, K Borrelli, W Yen, Q Ruan, M Chen, J Kelliher, J Scotellaro, ... NEUROPSYCHOPHARMACOLOGY 44 (SUPPL 1), 220-221, 2019 | | 2019 |
| Systems Genetic Analysis and Positional Cloning in a Reduced Complexity Cross Identifies a Major QTL on Distal Chromosome 1 Underlying Opioid Addiction Traits L Goldberg, S Kirkpatrick, A Luong, J Kelliher, K Luttik, J Wu, ER Reed, ... NEUROPSYCHOPHARMACOLOGY 43, S626-S627, 2017 | | 2017 |
